Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (7)

Company Market Cap Price
BDX Becton, Dickinson and Company
BD offers safety syringes and needle‑safety devices as part of its medical device offerings.
$55.23B
$192.32
-0.21%
CAH Cardinal Health, Inc.
Safety syringes manufacturing within CAH's medical devices portfolio.
$50.02B
$212.01
+1.21%
ATR AptarGroup, Inc.
Aptar provides safety syringe solutions, a discrete medical device category with recurring revenue potential.
$8.01B
$121.61
+0.07%
EMBC Embecta Corp.
Safety syringes are a key product category in Embecta's portfolio.
$851.51M
$14.47
-0.69%
KRMD KORU Medical Systems, Inc.
HIgH-Flo safety needle sets are direct product offerings used with the subcutaneous infusion system.
$221.00M
$4.90
+2.51%
RVP Retractable Technologies, Inc.
Core product category directly manufactured and sold: passive-safety syringes designed to prevent needlestick injuries.
$23.85M
$0.82
+3.16%
STSS Sharps Technology, Inc.
Core product category: Safety syringes (SafeGard/Sologard) with passive safety features.
$2.90M
$3.02
+6.89%

Loading company comparison...

Loading research report...

BDX Becton, Dickinson and Company

BD Launches Surgiphor™ Surgical Wound Irrigation System in Europe with CE Approval

Nov 24, 2025
BDX Becton, Dickinson and Company

BD Gains WHO Prequalification for Onclarity HPV Assay, Broadening Global Cervical Cancer Screening

Nov 17, 2025
RVP Retractable Technologies, Inc.

Retractable Technologies Reports Q3 2025 Results: Revenue Slightly Down, Operating Loss Narrowed

Nov 15, 2025
BDX Becton, Dickinson and Company

BD Completes Alaris EMR Interoperability Across All Major U.S. EHRs with First MEDITECH Implementation

Nov 13, 2025
KRMD KORU Medical Systems, Inc.

KORU Medical Systems Posts 27% Revenue Growth in Q3 2025, Raises Full‑Year Guidance

Nov 13, 2025
BDX Becton, Dickinson and Company

BD Introduces Portable PureWick Collection System for Wheelchair Users and Mobility‑Restricted Patients

Nov 12, 2025
BDX Becton, Dickinson and Company

Becton, Dickinson Reports Q4 2025 Earnings: Adjusted EPS Beats Estimates, Revenue Slightly Misses Forecasts

Nov 06, 2025
BDX Becton, Dickinson and Company

BD Reaches Full Enrollment of Iliac Artery Cohort in AGILITY Study for Revello Vascular Stent

Nov 04, 2025
BDX Becton, Dickinson and Company

BD Receives FDA 510(k) Clearance and CE‑IVDR Certification for New High‑Throughput Enteric Bacterial Panels

Nov 03, 2025
CAH Cardinal Health, Inc.

Cardinal Health Completes $1.9 Billion Acquisition of Solaris Health, Expanding Urology MSO Platform

Nov 03, 2025
ATR AptarGroup, Inc.

AptarGroup Reports Q3 2025 Earnings: Net Income $127.9 Million, EPS $1.92

Oct 31, 2025
CAH Cardinal Health, Inc.

Cardinal Health Reports Robust Q1 FY26 Earnings, Raises Guidance Amid Solaris Health Acquisition

Oct 30, 2025

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks